LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis
Shiliang Dong(First Affiliated Hospital of Zhengzhou University), Yonggang Shi(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Ming Li(Air Force Medical University), Xiaoxiao Zuo(First Affiliated Hospital of Zhengzhou University), Yuexin Guo(Beijing Institute of Technology), Minrui Ma(First Affiliated Hospital of Zhengzhou University), Xiaobin Gu(First Affiliated Hospital of Zhengzhou University)
Cited by 55
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134